Australian Trial to Test Medicinal Cannabis Against Chemotherapy’s Gut Side Effects
Cannabinoid clinical trials for chemotherapy mucositis are underway to evaluate CBD/THC's potential in preventing gastrointestinal side effects. This phase II trial tests sublingual wafers in adults receiving mucotoxic chemotherapy. Results are pending,…
Australian Trial to Test Whether Cannabis Can Prevent Chemotherapy Gut Damage: Protocol Published
The cannabis chemotherapy mucositis trial is the first rigorous study testing combined CBD and THC to prevent chemotherapy-induced gut damage. This protocol outlines the design of a phase II randomized controlled trial focused on gastrointestinal…
Cannabinoids in Combination with Conventional Breast Cancer Therapies: Mechanistic Insights and the Gap to Clinical Translation.
This review highlights cannabinoid anti-tumor effects breast cancer research and its potential to enhance conventional therapies. It emphasizes the gap between preclinical findings and clinical translation. Understanding these effects is crucial for…